Happy 60th Birthday Remifemin®

Remifemin®, the world’s leading natural menopause support brand, celebrates 60 years of supporting women worldwide naturally through peri menopause and menopause.

Formulated with all-natural ingredients by Germany's Schaper & Brümmer, Remifemin® is the number one Cimicifuga-only (Black Cohosh) preparation for menopause symptom relief worldwide, with more than 60 years of supporting usage and clinical research in addition to millions of users worldwide.

In 2013, Oxford University in the United Kingdom awarded the product top marks for safety and efficacy.

Top Marks for Remifemin®

Highest Level of Evidence (1) and Highest Grade of Recommendation (A)

The world’s first differentiated review of clinical studies examining the efficacy and safety of Cimicifuga racemosa (black cohosh) for menopausal complaints has been accepted for publication in the international peer-reviewed journal, Evidence-Based Complementary and Alternative Medicine (eCAM):

Why Not All Black Cohosh Products are the Same

Herbal extracts contain a multitude of ingredients and their composition varies depending on many factors, such as the extraction method. This may lead to different efficacies. Furthermore, a product’s quality (reflected in a regulatory status as a medicinal product) is a prerequisite for a reproducible efficacy and safety.

What sets this review apart from all other Cimicifuga reviews is that it corresponds with the characteristics of evidence-based phytotherapy by differentiating according to extract, quality and indication.

Accordingly, Oxford Levels of Evidence (LOE) and Grades of Recommendation (GR) have now been determined.

  • The LOE and GR system assists the busy clinician in making confident product recommendations: http://www.cebm.net/index.aspx?o=8111

From the Abstract[1]:

 “Only registered CR** medicinal products were able to prove their efficacy. Best evidence was provided by the isopropanolic CR extract (iCR): the multitude of studies including more than 11,000 patients demonstrated consistent confirmatory evidence of LOE 1b (LOE 1a for safety) leading to a GR A.”

The Grade of Recommendation A represents a seal of approval which is rarely achieved by herbal medicinal products and offers a profound basis for qualified counselling of climacteric patients.

[1]Beer, A.M and Neff A.,“Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa’s Efficacy and Safety for Climacteric Complaints”, eCAM, 2013, Article in press.

**Cimicifuga racemose

Remifemin product range includes:

  • Remifemin Tablets 60’s  RRP $34.90
  • Remifemin tablets 120’s RRP $59.00
  • Sleep by Remifemin 30’s RRP $29.90

Available at pharmacies and health stores nationwide.

 

 

About Remifemin®

Remifemin® is a naturally derived alternative to support women as they face and go through menopause. Available since 1956, Remifemin® is today used by millions of women around the world and has been the subject of several clinical trials published in peer-reviewed medical journals. Remifemin® is recognised as one of Germany's foremost herbal products made specifically for women's health at the age of menopause. It does not contain any form of oestrogen. Remifemin® is distributed by Synergy New Zealand.

Contact

Distributed by Synergy New Zealand Unit 9 22 Moselle Avenue Henderson Auckland New Zealand 0610

+64 9 838 3265

[email protected]

www.remifemin.co.nz